Hypershell takes $50M more on $120M Series B series as consumer exoskeletons step out of niche
Back to Home
tech

Hypershell takes $50M more on $120M Series B series as consumer exoskeletons step out of niche

May 19, 20264 views2 min read

Hypershell has raised $50 million in Series B+ funding, bringing its total Series B funding to $120 million at a post-money valuation of nearly $400 million. The round was co-led by Ant Group and Meituan Dragonball.

Shanghai-based consumer exoskeleton startup Hypershell has secured an additional $50 million in Series B+ funding, bringing its total Series B funding to $120 million. The round was co-led by Ant Group and Meituan Dragonball, with participation from Sofina and Granite Asia. The company is now valued at nearly $400 million post-money, ahead of its global launch of the X-Series exoskeleton.

Expanding Reach with Strategic Investments

The funding round underscores growing investor confidence in the consumer exoskeleton market, which has historically been limited to niche applications in industrial and medical sectors. Hypershell’s ability to attract major players like Ant Group, a leader in fintech and AI, and Meituan Dragonball, a prominent Chinese tech investor, signals the increasing commercial viability of wearable tech for everyday users.

The X-Series, set to launch globally, is expected to bring exoskeleton technology to a broader audience. Hypershell’s vision is to make exoskeletons as common as smartphones, focusing on enhancing mobility, reducing fatigue, and improving physical performance for consumers. This expansion marks a significant shift from the technology’s earlier use in rehabilitation or heavy-duty work environments.

Market Potential and Future Outlook

As the global wearable tech market continues to grow, companies like Hypershell are positioning themselves at the forefront of the next wave of consumer innovation. With support from major investors and a clear roadmap for product launches, the company is well-positioned to capture market share in the emerging exoskeleton space.

The funding will be used to scale production, accelerate research and development, and expand global distribution. Analysts suggest that as the technology becomes more accessible and affordable, adoption could surge across sectors including fitness, elderly care, and logistics.

Conclusion

Hypershell’s latest funding milestone reflects a broader trend toward mainstream adoption of wearable assistive technologies. As the company prepares to launch its X-Series, it’s not just a product release—it’s a step toward reshaping how consumers interact with physical assistance technology.

Source: TNW Neural

Related Articles